Zoetic International plc (LON:ZOE) has announced that its ordinary shares are now trading on the OTCQX® Best Market in the U.S., under the ticker symbol ZOEIF. The OTCQX® Best Market (“OTCQX”) is the highest level of the OTC markets. Zoetic upgraded to OTCQX from the OTCQB® Venture Market.
The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. investors.
Zoetic’s ordinary shares will continue to trade on the London Stock Exchange under the symbol ZOE.
In addition to the benefits of the OTCQX Market, the Company is currently evaluating additional opportunities to improve investor relations and communications in North America. The Zoetic directors believe the Company represents a unique opportunity for investors to access a company that is disrupting the tobacco industry with high quality CBD products on an international distribution platform.
In addition to OTCQX trading, the Company is also pleased to announce that it recently has been included in the MSCI Microcap Index. Inclusion in the index reflects the Company’s recent progress in transitioning to a pure play, integrated CBD company and the resultant increase in market capitalisation. The inclusion in the index is another step towards increasing Zoetic’s stock liquidity and investment profile in the U.S.
Trevor Taylor, Co-CEO of Zoetic International, commented, “The combination of trading on OTCQX and index inclusion reflect the Company’s tremendous progress towards transitioning to a pure play, integrated CBD company over the past 12 months. Our recent product development and wholesale distribution expansion have set the stage for the first leg of projected multi-year, sustainable growth for the Company. We couldn’t be more pleased with our progress to date, as well as our current position in this high-growth market.”
